Home › Ewing Sarcoma › Missouri › St. Louis
Ewing Sarcoma clinical trials in St. Louis, MO
3 studies for Ewing Sarcoma are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RecruitingPhase 1/2
- Cardinal Glennon Children's Medical Center, St Louis
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RecruitingPhase 1/2
- Cardinal Glennon Children's Medical Center, St Louis
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RecruitingPhase 1/2
- Washington University School of Medicine, St Louis
Ewing Sarcoma trials in other cities
- New York City, NY8 studies
- Houston, TX7 studies
- Memphis, TN7 studies
- Philadelphia, PA7 studies
- Los Angeles, CA6 studies
- Washington, DC6 studies
- Aurora, CO6 studies
- Boston, MA6 studies
- Birmingham, AL5 studies
- Atlanta, GA5 studies
- Cincinnati, OH5 studies
- Nashville, TN4 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer68 studies
- Breast Cancer63 studies
- Metastatic Cancer52 studies
- Cancer (all types)51 studies
- Colorectal Cancer51 studies
- Prostate Cancer45 studies
- Ovarian Cancer37 studies
- Lung Cancer37 studies
- Pancreatic Cancer33 studies
- Head and Neck Squamous Cell Carcinoma32 studies
- Endometrial Cancer29 studies
- Multiple Myeloma26 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.